Rocuronium Injection, Solution
Product Images NDC 65219-065

8 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 65219-065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Roc04 0006 01)

Structural Formula (Roc04 0006 01)
Chemical structure of ROCURONIUM BROMIDE with molecular formula C32H53BrN2O4 and molecular weight 609.70. The diagram shows the arrangement of atoms including bromide ion (Br-) and detailed structural components.*
FDA Label Image

Figure 1 (Roc04 0006 02)

Figure 1 (Roc04 0006 02)
A scatter plot chart showing distribution of a variable in minutes on the y-axis against Rocuronium dosage in mg/kg on the x-axis across three age groups: 18-64 years, 65 years and older, and 1-12 years. The plot includes data points and box plots for each dosage within the age groups.*
FDA Label Image

Figure 2 (Roc04 0006 03)

Figure 2 (Roc04 0006 03)
A box plot chart showing Rocuronium injection duration in minutes on the y-axis, stratified by age groups including 18-64 years, 65 years or older, 3 months to 1 year, and 1-12 years. The chart illustrates the variability of duration across these age categories.*
FDA Label Image

Figure 3 (Roc04 0006 04)

Figure 3 (Roc04 0006 04)
A line graph showing the relationship between dose number (x-axis) and time in minutes (y-axis) for Rocuronium at two different doses: 0.1 mg/kg and 0.15 mg/kg. The graph includes data points connected by lines and sample sizes (N=29 for 0.1 mg/kg and N=13 for 0.15 mg/kg).*
FDA Label Image

Fresenius Kabi Logo (Roc04 0006 05)

FDA Label Image

Package Label – Principal Display Panel – Rocuronium 5 mL Multiple Dose Vial Label (Roc04 0006 06)

Package Label – Principal Display Panel – Rocuronium 5 mL Multiple Dose Vial Label (Roc04 0006 06)
Label for Rocuronium Bromide Injection, 10 mg/mL (50 mg per 5 mL), a multiple dose vial for intravenous use. The label includes warnings about its paralyzing effect and respiratory arrest risk. It is labeled by Fresenius Kabi USA, LLC with storage instructions and barcode visible.*
FDA Label Image

Package Label – Principal Display Panel – Rocuronium 5 mL Multiple Dose Vial Tray Label (Roc04 0006 07)

Package Label – Principal Display Panel – Rocuronium 5 mL Multiple Dose Vial Tray Label (Roc04 0006 07)
Rocuronium Bromide Injection 10 mg/mL solution label for intravenous use. The label states a concentration of 50 mg per 5 mL in multiple dose vials (10 x 5 mL) by Fresenius Kabi USA, LLC. It includes warnings about its paralyzing effects and respiratory arrest risk, storage instructions, and barcode details.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Rocuronium Bromide Injection 10 mg per mL, a paralyzing agent for intravenous use. The label instructs to peel off and apply to syringe, with spaces for recording date, time, and initials of the person administering. The label is from Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.